Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
AVANT BIO is a Delaware limited liability company established to focus on the life sciences sector. Founded with the mission to partner with companies at the intersection of advanced technologies and novel therapeutics, AVANT BIO addresses unmet needs in therapeutic development. The firm operates with a clear vision of enhancing drug discovery and manufacturing processes through innovative investments.
Currently, AVANT BIO manages a focused portfolio of five companies, reflecting a strategic approach to investment in the life sciences. Their active investments span across North America and Europe, showcasing a commitment to geographical diversity. The firm emphasizes themes such as equitable access to therapies, speed and quality in drug discovery, and innovations in healthtech.
AVANT BIO invests primarily in therapeutic enabling technologies, biomanufacturing tools and automation, machine learning and AI applications, healthtech, techbio, and contract services. Their thematic focus includes ensuring equitable access to therapies globally, enhancing speed and quality in drug discovery, and developing new modalities. The firm also prioritizes robust manufacturing and supply chain solutions, clinical trial access and diversity, and innovations in healthtech.
AVANT BIO seeks to partner with companies that align with their mission of improving therapeutic development and access. They look for founders who demonstrate a commitment to addressing significant healthcare challenges through innovative solutions. The firm’s investment strategy reflects a deep understanding of the life sciences landscape and a dedication to supporting transformative technologies.
AVANT BIO's portfolio includes several notable companies that exemplify their investment strategy:
This diverse portfolio highlights AVANT BIO's commitment to investing in companies that are at the forefront of technological advancements in the life sciences sector.
Daniella Kranjac: Role not specified, but brings expertise in life sciences and investment strategies.
Sebastien Latapie: Role not specified, with a background in venture capital and technology investments.
Ole Henrik Bang-Andreasen: Role not specified, known for his experience in biotech and healthcare investments.
Founders should pitch to AVANT BIO through their website. It is important to include a comprehensive deck that outlines the business model, market opportunity, and how the company aligns with AVANT BIO's investment focus. Response times may vary, but founders can expect timely feedback on their submissions.
Recently, AVANT BIO led a Series B investment in Abbelight, showcasing their commitment to supporting innovative companies in the life sciences space. They have also published several blog posts, including a quarterly report and insights on significant industry deals, indicating active engagement with current trends in drug delivery and investment activities.
What are AVANT BIO's investment criteria?
AVANT BIO focuses on companies that operate at the intersection of advanced technologies and novel therapeutics. They prioritize investments in therapeutic enabling technologies, healthtech, and biomanufacturing tools.
How can I apply or pitch to AVANT BIO?
Founders can pitch their ideas through the AVANT BIO website at avant.bio. It is recommended to include a detailed business plan and information on how the company addresses unmet needs in therapeutic development.
What makes AVANT BIO different from other venture capital firms?
AVANT BIO emphasizes equitable access to therapies and innovations in clinical trial diversity, setting them apart in the life sciences investment landscape.
What is the geographic scope of AVANT BIO's investments?
The firm invests primarily in North America and Europe, reflecting a commitment to supporting innovative companies across these regions.
What is the typical check size for investments?
While specific check sizes are not disclosed, AVANT BIO's investments are typically aligned with the needs of the companies they support, focusing on significant contributions to enhance growth and development.
What kind of post-investment involvement does AVANT BIO have?
AVANT BIO actively engages with its portfolio companies, providing support in areas such as operational strategy, market access, and scaling their innovations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.